Holen Sie sich die Stockscreener-App
4.195
2.44%
0.10
Schlusskurs vom Vortag:
$4.095
Offen:
$4.12
24-Stunden-Volumen:
1,446
Relative Volume:
0.00
Marktkapitalisierung:
$6.73M
Einnahmen:
$3.19M
Nettoeinkommen (Verlust:
$-10.42M
KGV:
-0.1182
EPS:
-35.4757
Netto-Cashflow:
$-10.65M
1W Leistung:
-4.44%
1M Leistung:
-20.10%
6M Leistung:
-75.75%
1J Leistung:
-80.76%
1-Tages-Spanne:
$4.12
$4.195
1-Wochen-Bereich:
$3.87
$4.38
52-Wochen-Spanne:
$3.70
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Firmenname
Intelligent Bio Solutions Inc
Sektor
Branche
Telefon
646-790-5756
Adresse
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
4.195 | 6.58M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
110.14 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.22 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.94 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.86 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.24 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
Why Intelligent Bio Solutions Inc. stock is rated strong buyJuly 2025 Short Interest & Weekly High Return Stock Opportunities - Naître et grandir
How Intelligent Bio Solutions Inc. stock reacts to global recession fearsWeekly Profit Analysis & Target Return Focused Picks - Naître et grandir
Intelligent Bio Solutions announces reverse stock split - MSN
Intelligent Bio Solutions Scales Manufacturing to Fuel Growth and U.S. Ambitions - AD HOC NEWS
Jobs Data: How cyclical is Intelligent Bio Solutions Incs revenue stream2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
INBS receives first reader shipment from Syrma Johari partnership By Investing.com - Investing.com Australia
INBS receives first reader shipment from Syrma Johari partnership - Investing.com
Intelligent Bio Solutions Expands Manufacturing Capacity and Deployment - TipRanks
Intelligent Bio Solutions Inc. Plans U.S. Market Entry in 2026 - marketscreener.com
Why Did INBS Stock Jump 11% In Pre-Market Today? - Asianet Newsable
Intelligent Bio Solutions ships first readers with Syrma Johari, targets 40% production cost cuts - TradingView
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
Intelligent Bio Solutions announces delivery in partnership with Syrma Johari - marketscreener.com
Intelligent Bio Solutions (INBS) targets 40%+ cost savings with new Syrma Johari manufacturing - Stock Titan
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry - The Manila Times
Intelligent Bio Solutions Announces Delivery In Partnership With Syrma Johari - TradingView
Drug test readers scaled 4x as Intelligent Bio preps for U.S. entry - Stock Titan
Aug Final Week: What are the analyst revisions for CLFDIs ARQQW stock a good investment in YEARTrend Reversal & Fast Moving Trade Plans - baoquankhu1.vn
Aug Fed Impact: Will D Wave Quantum Inc Equity Warrant stock benefit from M AJuly 2025 Breakouts & Verified Swing Trading Watchlists - baoquankhu1.vn
Intelligent Bio Solutions (INBS) Collaborates with Bouygues UK o - GuruFocus
Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout - marketscreener.com
Intelligent Bio Solutions partners with Bouygues UK - marketscreener.com
Intelligent Bio Solutions Partners With Bouygues UK - TradingView
Intelligent Bio Solutions Inc. Partners with Bouygues UK for Deployment of Fingerprint Drug Screening Technology - Quiver Quantitative
Construction giant brings drug tests in-house with fingerprint scans at UK sites - Stock Titan
EPS Watch: Should I buy Intelligent Bio Solutions Inc stock now2025 Macro Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
INBS Should I Buy - Intellectia AI
Is Intelligent Bio Solutions Inc. a defensive stock2025 Analyst Calls & Smart Investment Allocation Tips - mfd.ru
Can Intelligent Bio Solutions Inc. maintain its current growth rateWeekly Risk Report & Consistent Profit Trade Alerts - mfd.ru
Is Intelligent Bio Solutions Inc. being accumulated by smart moneyWeekly Trend Report & Free Technical Pattern Based Buy Signals - mfd.ru
Intelligent Bio Solutions reports record fiscal second quarter revenue growth of 48% with reader sales surging 104% year-over-year - marketscreener.com
INBS Sees Strong Revenue Growth in Q2 - GuruFocus
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth Of 48% With Reader Sales Surging 104% Year-Over-Year - TradingView
Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year - The Manila Times
INTELLIGENT BIO SOLUTIONS INC's recently released fiscal second quarter earnings report shows the company achieved record revenue growth, with quarterly revenue surging 48% year-over-year. - Bitget
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Can Intelligent Bio Solutions Inc. stock deliver consistent earnings growthLong Setup & Weekly Momentum Stock Picks - mfd.ru
Is Intelligent Bio Solutions Inc.’s growth already priced inEarnings Recap Report & Technical Buy Zone Confirmations - mfd.ru
Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year - The Manila Times
Intelligent Bio Solutions Inc. Anticipates Record Revenue Growth in Fiscal Q2 2026 Driven by Strong Customer Base Expansion - Quiver Quantitative
How cyclical is Intelligent Bio Solutions Inc.’s revenue streamJuly 2025 PreEarnings & AI Driven Stock Reports - mfd.ru
Intelligent Bio Solutions begins clinical studies for FDA clearance By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Launches Codeine Screening Clinical Program - TipRanks
Intelligent Bio Solutions Inc Initiates Clinical Studies for FDA Submission - TradingView
Intelligent Bio Solutions begins clinical studies for FDA clearance - Investing.com
INBS Embarks on Clinical Study for Drug Screening System FDA App - GuruFocus
Intelligent Bio Solutions initiates additional studies for FDA 510k submission - TipRanks
Intelligent Bio Solutions Initiates Additional Clinical - GlobeNewswire
Fundamentals Check: Is Intelligent Bio Solutions Inc stock risky to hold now2025 Performance Recap & Long-Term Investment Growth Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Intelligent Bio Solutions Forges Manufacturing Alliance With Syrma Johari Medtech - Medical Product Outsourcing
Finanzdaten der Intelligent Bio Solutions Inc-Aktie (INBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):